JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bolch, W. E.
Right arrow Articles by Inglis, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolch, W. E.
Right arrow Articles by Inglis, B. A.

Considerations of Marrow Cellularity in 3-Dimensional Dosimetric Models of the Trabecular Skeleton

Wesley E. Bolch, PhD1, Phillip W. Patton, PhD1, Didier A. Rajon, MS1, Amish P. Shah, BS1, Derek W. Jokisch, PhD2 and Benjamin A. Inglis, PhD3

1 Department of Nuclear and Radiological Engineering, University of Florida, Gainesville, Florida
2 Department of Physics and Astronomy, Francis Marion University, Florence, South Carolina
3 Center for Structural Biology, University of Florida Brain Institute, University of Florida, Gainesville, Florida



View larger version (128K):

[in a new window]
 
FIGURE 1. Two-dimensional region of interest selected from 3D NMR image of trabecular bone sample sectioned from male femoral head. Four values of marrow cellularity are displayed: 10% (A), 50% (B), 80% (C), and 100% (D). Gray voxels represent simulated adipocyte cell clusters defining inactive marrow tissue.

 


View larger version (27K):

[in a new window]
 
FIGURE 2. Electron absorbed fractions calculated for 10%, 30%, 50%, 80%, and 100% marrow cellularity using macrostructural transport model for femoral head of 51-y-old man. Values shown are average absorbed fractions of 2 separate bone samples sectioned from femoral head (<4% variation at high energies).

 


View larger version (25K):

[in a new window]
 
FIGURE 3. Electron absorbed fractions calculated for 10%, 30%, 50%, 80%, and 100% marrow cellularity using macrostructural transport model for humeral epiphysis of 51-y-old man.

 


View larger version (27K):

[in a new window]
 
FIGURE 4. Specific absorbed fractions for monoenergetic electrons calculated for 10%, 30%, 50%, 80%, and 100% marrow cellularity using macrostructural transport model for femoral head of 51-y-old man.

 


View larger version (25K):

[in a new window]
 
FIGURE 5. Electron absorbed fractions for self-irradiation of TAM within femoral head of 51-y-old man. Three dosimetry methodologies are compared. Method of Bouchet et al. (27,28) assumes that TAM self-absorbed fractions are equal to TMS self-absorbed fractions, whereas method of Eckerman and Stabin (15) scales TMS self-absorbed fractions by reference cellularity factor (0.25 for femoral head). TAM self-absorbed fractions reported in this study are calculated directly using macrostructural transport model of EGS4 transport code (solid line, no data points). Dashed lines indicate potential variations in absorbed fraction with changes in individual marrow cellularity either lower than that of reference man (10%) or higher than that of reference man (40%).

 


View larger version (27K):

[in a new window]
 
FIGURE 6. Electron-specific absorbed fractions for self-irradiation of TAM within femoral head of 51-y-old man. Values are obtained by dividing each curve in Figure 5 by corresponding mass of active marrow. Dashed lines indicate potential variations in specific absorbed fraction with changes in individual marrow cellularity either lower than that of reference man (10%) or higher than that of reference man (40%).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.